Accès gratuit
Volume 24, Numéro 2, Mars 2015
Page(s) 152 - 164
Section Mise Au Point / Update
Publié en ligne 4 mars 2015
  • Khairy P, Ionescu-Ittu R, Mackie AS, et al (2010) Changing mortality in congenital heart disease. J Am Coll Cardiol 56:1149–1157 [CrossRef] [PubMed] [Google Scholar]
  • Regitz-Zagrosek V, Blomstrom Lundqvist C, et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197 [CrossRef] [PubMed] [Google Scholar]
  • Siu SC, Sermer M, Colman JM, et al (2001) Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104:515–521 [CrossRef] [PubMed] [Google Scholar]
  • Cantwell R, Clutton-Brock T, Cooper G, et al (2011) Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 118(Suppl 1):1–203 [Google Scholar]
  • Edouard DA, Pannier BM, London GM, et al (1998) Venous and arterial behavior during normal pregnancy. Am J Physiol 274(5 Pt 2):H1605–H1612 [PubMed] [Google Scholar]
  • Slangen BF, van Ingen Schenau DS, van Gorp AW, et al (1997) Aortic distensibility and compliance in conscious pregnant rats. Am J Physiol 272(3 Pt 2):H1260–H1265 [PubMed] [Google Scholar]
  • Mone SM, Sanders SP, Colan SD. (1996) Control mechanisms for physiological hypertrophy of pregnancy. Circulation 94:667–672 [CrossRef] [PubMed] [Google Scholar]
  • Chesnutt AN. (2004) Physiology of normal pregnancy. Crit Care Clin 20:609–615 [CrossRef] [PubMed] [Google Scholar]
  • Faivre A, Lacroix G, Montcriol A, et al (2009) Wernicke’s encephalopathy presenting as unexplained coma with hyperlactatemia. Ann Fr Anesth Reanim 28:995–997 [CrossRef] [PubMed] [Google Scholar]
  • Mesa A, Jessurun C, Hernandez A, et al (1999) Left ventricular diastolic function in normal human pregnancy. Circulation 99:511–517 [CrossRef] [PubMed] [Google Scholar]
  • van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al (2014) Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 35:2165–2173 [CrossRef] [PubMed] [Google Scholar]
  • Sliwa K, Fett J, Elkayam U. (2006) Peripartum cardiomyopathy. Lancet 368:687–693 [CrossRef] [PubMed] [Google Scholar]
  • Cataldo L, Chen NY, Yuan Q, et al (2000) Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells. Int J Oncol 17:1179–1185 [PubMed] [Google Scholar]
  • Hilfiker-Kleiner D, Kaminski K, Podewski E, et al (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600 [CrossRef] [PubMed] [Google Scholar]
  • Corbacho AM, Martinez De La Escalera G, Clapp C. (2002) Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 173:219–238 [CrossRef] [PubMed] [Google Scholar]
  • Patten IS, Rana S, Shahul S, et al (2012) Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485:333–338 [CrossRef] [PubMed] [Google Scholar]
  • Hoes MF, van Hagen I, Russo F, et al (2014) Peripartum cardiomyopathy: Euro Observational Research Program. Neth Heart J 22:396–400 [CrossRef] [Google Scholar]
  • Bachelier-Walenta K, Hilfiker-Kleiner D, Sliwa K. (2013) Peripartum cardiomyopathy: update 2012. Curr Opin Crit Care 19:397–403 [CrossRef] [PubMed] [Google Scholar]
  • Haghikia A, Podewski E, Libhaber E, et al (2013) Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108:366. [CrossRef] [PubMed] [Google Scholar]
  • Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, et al (2014) Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail 7:300–309 [CrossRef] [PubMed] [Google Scholar]
  • Sliwa K, Blauwet L, Tibazarwa K, et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121:1465–1473 [CrossRef] [PubMed] [Google Scholar]
  • Iffy L, Lindenthal J, McArdle JJ, Ganesh V. (1996) Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression. Isr J Med Sci 32:309–312 [PubMed] [Google Scholar]
  • Hopp L, Haider B, Iffy L. (1996) Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement. Int J Cardiol 57:227–232 [CrossRef] [PubMed] [Google Scholar]
  • McNamara MS, Fealy GM. (2013) Editorial: Towards a future nursing education landscape. J Clin Nurs 22:1789–1790 [CrossRef] [PubMed] [Google Scholar]
  • Fett JD. (2014) Peripartum cardiomyopathy: A puzzle closer to solution. World J Cardiol 6:87–99 [CrossRef] [PubMed] [Google Scholar]
  • Fett JD, Fristoe KL, Welsh SN. (2010) Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers. Int J Gynaecol Obstet 109:34–36 [CrossRef] [PubMed] [Google Scholar]
  • Nasiell J, Lindqvist PG. (2010) Aortic dissection in pregnancy: the incidence of a life-threatening disease. Eur J Obstet Gynecol Reprod Biol 149:120–121 [CrossRef] [PubMed] [Google Scholar]
  • Rajagopalan S, Nwazota N, Chandrasekhar S. (2014) Outcomes in pregnant women with acute aortic dissections: a review of the literature from 2003 to 2013. Int J Obstet Anesth 23:348–356 [CrossRef] [PubMed] [Google Scholar]
  • Mana E, Buteler B. (1967) Test with a bronchodilator aerosol in the evaluation of expiratory obstruction to the passage of air. Prensa Med Argent 54:876–879 [PubMed] [Google Scholar]
  • Ohlson L. (1978) Effects of the pregnant uterus on the abdominal aorta and its branches. Acta Radiol Diagn (Stockh) 19:369–376 [PubMed] [Google Scholar]
  • Gersony DR, McClaughlin MA, Jin Z, Gersony WM. (2007) The effect of beta-blocker therapy on clinical outcome in patients with Marfan’s syndrome: a meta-analysis. Int J Cardiol 114:303–308 [CrossRef] [PubMed] [Google Scholar]
  • Immer FF, Bansi AG, Immer-Bansi AS, et al (2003) Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 76:309–314 [CrossRef] [PubMed] [Google Scholar]
  • Houston L, Tuuli M, Macones G. (2011) Marfan syndrome and aortic dissection in pregnancy. Obstet Gynecol 117:956–960 [CrossRef] [PubMed] [Google Scholar]
  • Chandrasekhar S, Cook CR, Collard CD. (2009) Cardiac surgery in the parturient. Anesth Analg 108:777–785 [CrossRef] [PubMed] [Google Scholar]
  • Hiratzka LF, Bakris GL, Beckman JA, et al (2010) 2010 ACCF/ AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 121:e266–e369 [CrossRef] [PubMed] [Google Scholar]
  • Joyal D, Leya F, Koh M, et al (2007) Troponin I levels in patients with preeclampsia. Am J Med 120 819.e13–e14 [CrossRef] [Google Scholar]
  • Roth A, Elkayam U. (2008) Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 52:171–180 [CrossRef] [PubMed] [Google Scholar]
  • James AH, Jamison MG, Biswas MS, et al (2006) Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 113:1564–1571 [CrossRef] [PubMed] [Google Scholar]
  • Puskin JS. (2009) Perspective on the use of LNT for radiation protection and risk assessment by the U.S. Environmental Protection Agency. Dose Response 7:284–291 [Google Scholar]
  • Fryearson J, Adamson DL. (2014) Heart disease in pregnancy: ischaemic heart disease. Best Pract Res Clin Obstet Gynaecol 28:551–562 [CrossRef] [PubMed] [Google Scholar]
  • Einav S, Kaufman N, Sela HY. (2012) Maternal cardiac arrest and perimortem caesarean delivery: evidence or expert-based? Resuscitation 83:1191–1200 [CrossRef] [PubMed] [Google Scholar]
  • Jennett B, Bond M. (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484 [CrossRef] [PubMed] [Google Scholar]
  • Baghirzada L, Balki M. (2013) Maternal cardiac arrest in a tertiary care centre during 1989–2011: a case series. Can J Anaesth 60:1077–1084 [CrossRef] [PubMed] [Google Scholar]
  • Duflou J, Virmani R, Rabin I, et al (1995) Sudden death as a result of heart disease in morbid obesity. Am Heart J 130:306–313 [CrossRef] [PubMed] [Google Scholar]
  • Galinier M, Pathak A, Roncalli J, Massabuau P. (2005) Obesity and cardiac failure. Arch Mal Coeur Vaiss 98:39–45 [Google Scholar]
  • Goodwin AP, Pearce AJ. (1992) The human wedge. A manoeuvre to relieve aortocaval compression during resuscitation in late pregnancy. Anaesthesia 47:433–434 [CrossRef] [PubMed] [Google Scholar]
  • Rees GA, Willis BA. (1998) Resuscitation in late pregnancy. Anaesthesia 43:347–349 [CrossRef] [Google Scholar]
  • Soar J, Perkins GD, Abbas G, et al (2010) European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 81:1400–1433 [CrossRef] [PubMed] [Google Scholar]
  • Jeejeebhoy FM, Zelop CM, Windrim R, et al (2011) Management of cardiac arrest in pregnancy: a systematic review. Resuscitation 82:801–809 [CrossRef] [PubMed] [Google Scholar]
  • Nanson J, Elcock D, Williams M, Deakin CD. (2001) Do physiological changes in pregnancy change defibrillation energy requirements? Br J Anaesth 87:237–239 [CrossRef] [PubMed] [Google Scholar]
  • Katz VL. (2012) Perimortem cesarean delivery: its role in maternal mortality. Semin Perinatol 36:68–72 [CrossRef] [PubMed] [Google Scholar]
  • Abenhaim HA, Azoulay L, Kramer MS, Leduc L. (2008) Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States. Am J Obstet Gynecol 199 49.e41–e48 [Google Scholar]
  • Knight M, Berg C, Brocklehurst P, et al (2012) Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth 12:7. [CrossRef] [PubMed] [Google Scholar]
  • McDonnell NJ, Percival V, Paech MJ. (2013) Amniotic fluid embolism: a leading cause of maternal death yet still a medical conundrum. Int J Obstet Anesth 22:329–336 [CrossRef] [PubMed] [Google Scholar]
  • Knight M, Tuffnell D, Brocklehurst P, et al (2010) Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 115:910–917 [CrossRef] [PubMed] [Google Scholar]
  • Conde-Agudelo A, Romero R. (2009) Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 201 445.e441–e443 [Google Scholar]
  • Clark SL, Hankins GD, Dudley DA, et al (1995) Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 172(4 Pt 1):1158–1167 [CrossRef] [PubMed] [Google Scholar]
  • Moore J, Baldisseri MR. (2005) Amniotic fluid embolism. Crit Care Med 33(10 Suppl):S279–S285 [CrossRef] [PubMed] [Google Scholar]
  • Benson MD. (2007) A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses 68:1019–1025 [CrossRef] [PubMed] [Google Scholar]
  • Oi H, Naruse K, Noguchi T, et al (2010) Fatal factors of clinical manifestations and laboratory testing in patients with amniotic fluid embolism. Gynecol Obstet Invest 70:138–144 [CrossRef] [PubMed] [Google Scholar]
  • Kobayashi H, Ohi H, Terao T. (1993) A simple, noninvasive, sensitive method for diagnosis of amniotic fluid embolism by monoclonal antibody TKH-2 that recognizes NeuAc alpha 2–6GalNAc. Am J Obstet Gynecol 168:848–853 [CrossRef] [PubMed] [Google Scholar]
  • Benson MD, Kobayashi H, Silver RK, et al (2001) Immunologic studies in presumed amniotic fluid embolism. Obstet Gynecol 97:510–514 [PubMed] [Google Scholar]
  • Legrand M, Rossignol M, Dreux S, et al (2012) Diagnostic accuracy of insulin-like growth factor binding protein-1 for amniotic fluid embolism. Crit Care Med 40:2059–2063 [CrossRef] [PubMed] [Google Scholar]
  • Benson MD. (2012) Current concepts of immunology and diagnosis in amniotic fluid embolism. Clin Dev Immunol 2012:946576. [CrossRef] [PubMed] [Google Scholar]
  • Bedard E, Dimopoulos K, Gatzoulis MA. (2009) Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 30:256–265 [CrossRef] [PubMed] [Google Scholar]
  • Presbitero P, Somerville J, Stone S, et al (1994) Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 89:2673–2676 [Google Scholar]
  • Hameed A, Karaalp IS, Tummala PP, et al (2001) The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 37:893–899 [CrossRef] [PubMed] [Google Scholar]
  • Silversides CK, Colman JM, Sermer M, Siu SC. (2003) Cardiacrisk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 91:1382–1385 [CrossRef] [PubMed] [Google Scholar]
  • Elkayam U, Bitar F. (2005) Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol 46:223–230 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.